You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 1, January 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Pulmonary Diseases, Other
 •Surgical Oncology
 •Thoracic Surgery
 •Lung Cancer
 •Alert me on articles by topic

Benefit of Surgical Treatment of Lung Metastasis in Soft Tissue Sarcoma

Alexander Rehders, MD; Stefan B. Hosch, MD; Peter Scheunemann, MD; Nikolas H. Stoecklein, MD; Wolfram T. Knoefel, MD; Matthias Peiper, MD

Arch Surg. 2007;142(1):70-75.

Hypothesis  Patients with pulmonary metastatic soft tissue sarcoma benefit from resection, with long-term cure possible.

Design  Retrospective medical records review.

Setting  Academic tertiary care center.

Patients  Between January 1, 1991, and December 31, 2002, 61 patients (33 men and 28 women; median age at initial diagnosis, 42 years [age range, 18-74 years]) were surgically treated for pulmonary metastases of soft tissue sarcoma at University Hospital, Hamburg-Eppendorf, Germany.

Interventions  Sternotomy or anterior lateral thoracotomy was performed for metastasectomy, including wedge resection or lobectomy.

Main Outcome Measure  The effects of clinical and pathologic factors on disease-specific survival were analyzed using the log rank test and a multivariate Cox proportional hazards model.

Results  Primary tumor size was pT1 in 13 patients and pT2 in 48 patients. The differentiation was high in 7 patients, intermediate in 19 patients, and low in 35 patients. The mean number of resected pulmonary metastatic lesions was 5 (range, 1-48). An anterolateral thoracotomy was performed in 39 patients, and sternotomy in 22 patients. There were no significant postoperative complications that required surgical revision. The perioperative mortality was 0%. At a mean follow-up of 60 months, the mean survival time after metastasectomy was 33 months (range, 2-125 months). The 5-year survival was 25%. The number of resected lung metastatic lesions had no prognostic relevance (P = .37).

Conclusions  Patients with lung metastasis from soft tissue sarcomas benefit from surgical excision. This treatment has low complication rates and has a favorable influence on the course of the disease. Long-term survival is possible even when recurrent pulmonary disease is resected.


Author Affiliations: Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Düsseldorf (Drs Rehders, Hosch, Scheunemann, Stoecklein, Knoefel, and Peiper); Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Universitätsklinikum Hamburg-Eppendorf (Drs Rehders, Hosch, Scheunemann, Stoecklein, Knoefel, and Peiper), Germany.


RELATED ARTICLE

Benefit of Surgical Treatment of Lung Metastasis in Soft Tissue Sarcoma—Invited Critique
M. Margaret Kemeny
Arch Surg. 2007;142(1):76.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Treatment of Sarcomatous Lung Metastases
Pass and Bizekis
Am Soc Clin Oncol Ed Book 2008;2008:519-522.
ABSTRACT | FULL TEXT  

Urgent pneumonectomy for metastatic sarcoma.
Gibbaoui and Yaman
J. Thorac. Cardiovasc. Surg. 2007;134:1599-1600.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.